| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/28/2005 | WO2005068472A1 Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases |
| 07/28/2005 | WO2005068469A1 Multi-nuclear metal complexes partially encapsulated by cucurbit[7-12]urils |
| 07/28/2005 | WO2005068468A2 Heterocyclic protein kinase inhibitors and uses thereof |
| 07/28/2005 | WO2005068467A1 Novel fused-ring compound |
| 07/28/2005 | WO2005068462A1 Diaza-spiropiperidine derivatives as inhibitors of transporter 1 and glycine transporter 2 |
| 07/28/2005 | WO2005068461A1 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| 07/28/2005 | WO2005068460A1 Isothiazole dioxides as cxc- and cc- chemokine receptor ligands |
| 07/28/2005 | WO2005068451A2 Methods for the synthesis of dictyostatin and derivatives and analogues thereof, stereochemical characterisation, novel dictyostatin compounds and uses thereof and synthetic intermediates |
| 07/28/2005 | WO2005068450A1 4-thio coumarins |
| 07/28/2005 | WO2005068442A2 Isoxazole derivatives and their use as cyclooxygenase inhibitors |
| 07/28/2005 | WO2005068437A1 2, 4 - diaminopyrimidines and their use for inducing cardiomyogenesis |
| 07/28/2005 | WO2005068429A1 Derivatives of pyridine and quinoline |
| 07/28/2005 | WO2005068425A1 New crystalline form of perindopril |
| 07/28/2005 | WO2005068424A1 Indolinone derivatives as receptor tyrosine kinase ihibitors |
| 07/28/2005 | WO2005067994A1 Crosslinked hyaluronic acid compositions for tissue augmentation |
| 07/28/2005 | WO2005067990A1 Methods, compositions, and devices for embolizing body lumens |
| 07/28/2005 | WO2005067979A1 Ahybrid of itraconazole with a layered silicate |
| 07/28/2005 | WO2005067975A1 Title: a sustained release captopril formulation having a supermolecular intercalation structure and the preparation process thereof |
| 07/28/2005 | WO2005067974A1 Drug for regulating cancer metastasis to bone |
| 07/28/2005 | WO2005067973A2 Combination of crf antagonists and 5-ht 1b receptor antagonists |
| 07/28/2005 | WO2005067972A1 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 07/28/2005 | WO2005067971A1 Drug for preventing and treating arteriosclerosis |
| 07/28/2005 | WO2005067969A2 Combinations of serotonin reuptake inhibitors and imidazoline-i2-agonists |
| 07/28/2005 | WO2005067962A2 Composition derived from milk goat comprising growth factors and oligosaccharides |
| 07/28/2005 | WO2005067950A1 Kava-kava extract for reducing the toxic and side effects and composition comprising the same and preparation thereof |
| 07/28/2005 | WO2005067944A1 Agent for treating inflammatory diseases |
| 07/28/2005 | WO2005067943A1 Compostions comprising glycosaminoglycan and nonsteroidal anti-inflammatory drug |
| 07/28/2005 | WO2005067942A1 Glycosaminoglycan peptides derived from connective tissues and use thereof in the prevention of arthritis and other degenerative medical conditions |
| 07/28/2005 | WO2005067941A1 Topical aciclovir formulation |
| 07/28/2005 | WO2005067940A1 Novel use of water soluble glucan oligomer isolated from saccharomyces cerevisiae is2 for prevention and treatment of avian flu |
| 07/28/2005 | WO2005067939A1 Therapeutically useful antibacterial compounds |
| 07/28/2005 | WO2005067938A1 Menstrual cycle control and improvement of conception rates in females |
| 07/28/2005 | WO2005067937A1 Neutral endopeptidase (nep) and human soluble endopeptidase (hsep) inhibitors for prophylaxis and treatment of neurodegenerative disorders |
| 07/28/2005 | WO2005067936A2 Methods for the production of sildenafil base and citrate salt |
| 07/28/2005 | WO2005067935A1 Use of substituted pteridines for the treatment of diseases of the respiratory tract |
| 07/28/2005 | WO2005067934A1 Use of substituted pyrimido pyrimido[5,4-d]pyrimidines in the treatment of diseases of the respiratory tract |
| 07/28/2005 | WO2005067933A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d) (1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
| 07/28/2005 | WO2005067932A1 (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 07/28/2005 | WO2005067931A2 Dopamine uptake inhibitors for the treatment of neurological disease |
| 07/28/2005 | WO2005067930A2 Serotonin receptor antagonists for the treatment of neurological disease |
| 07/28/2005 | WO2005067929A1 New pharmaceutical compositions based on a scopineester and nicotinamide derivatives |
| 07/28/2005 | WO2005067928A1 Method for treating erectile dysfunction |
| 07/28/2005 | WO2005067927A2 The use of quaternary pyridinium salts as vasoprotective agents |
| 07/28/2005 | WO2005067926A1 Pharmaceutical composition of amlodipine maleate having enhanced stability |
| 07/28/2005 | WO2005067925A1 Derivatives of aryl(or heteroaryl) azolylcarbinols for the treatment of enuresis |
| 07/28/2005 | WO2005067924A1 Use of pilocarpine for hypoptyalism treatment |
| 07/28/2005 | WO2005067921A1 Pharmaceutical compositions comprising higher primary aliphatic alcohols and hmg coa reductase inhibitor and process of preparation thereof |
| 07/28/2005 | WO2005067920A1 Therapeutic drugs for arthritis |
| 07/28/2005 | WO2005067919A1 11-csubsituted erythromycin derivatives |
| 07/28/2005 | WO2005067918A1 Active oxygen eliminator originating in natural material and use of the same |
| 07/28/2005 | WO2005067917A1 Therapeutic use of quinonoid derivatives of cannabinoids |
| 07/28/2005 | WO2005067916A1 Weak to average strength opioids or combinations of said opioids containing antidepressants for the treatment of depressions and anxiety disorders |
| 07/28/2005 | WO2005067915A1 Synergistic neuroprotective combinations of flavanols, hydroxystilbenes, flavanones, flavones, flavonols, proanthocyanidins and anthocyanidins |
| 07/28/2005 | WO2005067914A1 Preventive or ameliorating agent for liver disease involving hepatopathy |
| 07/28/2005 | WO2005067913A1 Lipase inhibitor |
| 07/28/2005 | WO2005067912A1 Method of intentionally, noninvasively, therapeutically modulating fat in a living mammal |
| 07/28/2005 | WO2005067911A1 (2S)-AMINO(PHENYL)ACETIC ACID AND DERIVATIVES AS α2δ VOLTAGE-GATED CALCIUM CHANNEL LIGANDS |
| 07/28/2005 | WO2005067910A1 Tulobuterol adhesive patch |
| 07/28/2005 | WO2005067909A1 Combination therapy with mecamylamine for the treatment of mood disorders |
| 07/28/2005 | WO2005067908A2 Memantine for the treatment of mild and mild-to-moderate alzheimer’s disease |
| 07/28/2005 | WO2005067907A1 Reagent for lacrimation examination and method of lacrimation examination |
| 07/28/2005 | WO2005067906A2 Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol |
| 07/28/2005 | WO2005067905A1 Propofol-containing fat emulsion preparation |
| 07/28/2005 | WO2005067904A1 Abca1 stabilizer |
| 07/28/2005 | WO2005067903A1 Pharmaceutical compositions comprising higher primary alcohols and ezetimibe and process of preparation thereof |
| 07/28/2005 | WO2005067902A1 Novel compositions comprising higher primary alcohols and nicotinic acid and process of preparation thereof |
| 07/28/2005 | WO2005067901A2 Methods for treating and preventing hypertension and hypertension-related disorders |
| 07/28/2005 | WO2005067900A2 Azabenzofuran substituted thioureas as inhibitors of viral replication |
| 07/28/2005 | WO2005067899A2 Methods for treating stress and affecting biological immune systems using a cysteamine compound |
| 07/28/2005 | WO2005067897A1 Transdermal delivery device for dihydropyridine type calcium antagonists containing at least one fatty acid |
| 07/28/2005 | WO2005067895A1 Controlled release pharmaceutical compositions |
| 07/28/2005 | WO2005067893A2 Pharmaceutical compositions comprising midazolam in a high concentration |
| 07/28/2005 | WO2005067892A1 Lipid compositions and methods of use |
| 07/28/2005 | WO2005067891A1 Compositions comprosing memantine and polyanionic polymers for administration to the eye |
| 07/28/2005 | WO2005067887A2 Formulations of ramipril |
| 07/28/2005 | WO2005067878A1 Polysaccharide alcohol antiseptic gel |
| 07/28/2005 | WO2005067873A1 Topical solutions comprising high concentrations of piperidinopyrimidine derivatives and methods of use thereof |
| 07/28/2005 | WO2005067738A1 Glycine-containing food and use thereof |
| 07/28/2005 | WO2005067719A1 Chitosan-psyllium complexes and methods for making and using same |
| 07/28/2005 | WO2005067673A2 Enzymatic method to produce 7-dehydropregnenolone, vitamin d3-like compounds and derivatives thereof |
| 07/28/2005 | WO2005067632A2 Lipid compositions and use thereof |
| 07/28/2005 | WO2005067627A2 Cosmetic composition and method for retarding hair growth |
| 07/28/2005 | WO2005067564A2 6-11 bicyclic erythromycin derivatives |
| 07/28/2005 | WO2005067548A2 Use of ribose in recovery from anaesthesia |
| 07/28/2005 | WO2005067546A2 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases |
| 07/28/2005 | WO2005067502A2 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| 07/28/2005 | WO2005067500A2 Enhancement of immune responses |
| 07/28/2005 | WO2005067489A2 Type ii diabetes |
| 07/28/2005 | WO2005067388A2 Perturbed membrane-binding compounds and methods of using the same |
| 07/28/2005 | WO2005067363A2 Use of pyrimidine nucleotides for increasing muscle power |
| 07/28/2005 | WO2005056708A3 Bioadhesive polymers with catechol functionality |
| 07/28/2005 | WO2005056024A9 Methods of enhancing stem cell engraftment |
| 07/28/2005 | WO2005055963A3 Decontamination formulation with sorbent additive |
| 07/28/2005 | WO2005051953A3 Pyrrolo-pyrazine derivatives useful as cb1-modulators |
| 07/28/2005 | WO2005051433B1 Method for treating human tumor cells with a newcastle disease virus strain and a chemotherapeutic agent |
| 07/28/2005 | WO2005051410A9 Hepatitis c virus inhibitors |
| 07/28/2005 | WO2005051349A3 Pharmaceutical compositions of mirtazapine |
| 07/28/2005 | WO2005051296A3 Fused ring dicationic anti-protozoan agents and their prodrugs |
| 07/28/2005 | WO2005049211A3 Fiber rich fraction of trigonella foenum-graceum seeds and its use as a pharmaceutical excipient |
| 07/28/2005 | WO2005048982A3 Efficient introduction of an aerosol into a ventilator circuit |